| Patent Number |
Title Of Patent |
Date Issued |
| 5741517 |
Water-containing liposome system |
April 21, 1998 |
| An aqueous liposome system which contains at least one phospholipid and selectively a non-toxic organic solvent. In addition to the at least one phospholipid the liposome system contains at least one phospholipidic charge carrier. |
| 5556637 |
Water containing liposome system |
September 17, 1996 |
| An aqueous liposome system which contains at least one phospholipid and selectively a non-toxic organic solvent. In addition to the at least one phospholipid the liposome system contains at least one phospholipidic charge carrier. |
| 4842865 |
Use of glycofurol for the liquidization of pharmaceutical preparations to be filled into soft ge |
June 27, 1989 |
| Use of glycofurol for the liquidization of pharmaceutical preparations containing more than 50% phosphatidyl choline with a high content of unsaturated fatty acids, which preparations can contain another active ingredient as well as phosphatidyl choline, and in which the viscosity so |
| 4687766 |
Pharmaceutical preparation for the therapeutic treatment of rheumatic diseases |
August 18, 1987 |
| Pharmaceutical preparation containing phospholipids for the therapeutic treatment of rheumatic diseases which contain in addition to the antiphlogistically acting oxicam derivatives of the general formula ##STR1## special 1,2-diacyl-glycero-3-phosphocholines wherein 75-86% by weight |
| 4684632 |
Formulation with special 1,2-diacylglycero-3-phosphocholines for the treatment of gastrointestin |
August 4, 1987 |
| Pharmaceutical formulations for the treatment of gastrointestinal disorders, which contain as the active component an effective gastrointestinal disorder alleviating amount of a 1,2-diacylglycero-3-phosphocholine in which 75-86% by weight of the acyl radicals are unsaturated fatty ac |
| 4567202 |
Pharmaceutical amitriptylin oxide preparation and process for its manufacture |
January 28, 1986 |
| Stable pharmaceutical preparations comprising amitriptylin oxide dihydrate as an active substance and an organic acid from the group of hydroxy carboxylic acids, ketocarboxylic acids or amino acids as a stabilizer besides conventional pharmaceutical auxiliaries and carrier substances. |
